TKNO logo

Alpha Teknova (TKNO)

Profile

Full Name

Alpha Teknova, Inc.

Ticker Symbol

TKNO

Exchange

NASDAQ

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

United States

IPO

June 25, 2021

Indexes

Not included

Website

http://www.teknova.com

Employees

173

Key Details

Price

$5.77(-1.03%)

Market cap

$308.33M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$37.74M(+2.89% YoY)

Annual EPS

-$0.57(+50.86% YoY)

PE ratio

-

Next earnings date

May 13, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$5.77
TKNO price is $5.77

30-Day Relative Volume

0.67
TKNO 30-day relative volume is 0.67

Price Performance

Price Today change

-1.03%
TKNO price is down -1.03% today

Price YTD change

-30.9%
TKNO price is down -30.9% since January 1st

Price 1-year change

+121.92%
TKNO price is up +121.92% year-on-year

Price 3-year change

-63.34%
TKNO price is down -63.34% over the past 3 years

Price Range

Price All-time high

$30.89
TKNO price is currently -81.32% below its historical high of $30.89

Price 3-year low

$1.16
TKNO price is currently +399.57% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$308.33M
TKNO market capitalization is $308.33 million

Market cap 3-year change

-30.15%
TKNO market capitalization is down -30.15% over the past 3 years

Market cap All-time high

$770.05M
TKNO market capitalization is currently -59.96% below its historical high of $770.05 million

Market cap sector rank

63.49%
TKNO market capitalization is higher than 63.49% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+30.9%
TKNO shares outstanding is up +30.9% year-on-year

Shares Outstanding 3-Year Change

+90.56%
TKNO shares outstanding is up +90.56% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.39
TKNO beta is 1.39

200-day SMA

$5.94
TKNO price is currently -2.90% below its 200-day simple moving average

50-day SMA

$6.35
TKNO price is currently -9.18% below its 50-day simple moving average

RSI

51.78
TKNO 14-day relative strength index is 51.78

Volume

0.67
TKNO 30-day relative volume is 0.67

ATR

$0.57
TKNO average true range is $0.57

10-day Historical Volatility

144.96%
TKNO 10-day historical volatility is 144.96%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$37.74M
TKNO annual revenue is $37.74 million

Revenue Analysts estimate

$40.52M
TKNO annual revenue is currently -6.85% lower than the consensus analysts' forecast

Revenue 1-year change

+2.89%
TKNO annual revenue is up +2.89% year-on-year

Revenue Sector rank

43.46%
TKNO annual revenue is higher than 43.46% of companies in Healthcare sector

EPS

EPS

-$0.57
TKNO annual earnings per share is -$0.57

EPS Analysts estimate

-
TKNO annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

+50.86%
TKNO annual earnings per share is up +50.86% year-on-year

EPS Sector rank

66.28%
TKNO annual earnings per share is higher than 66.28% of companies in Healthcare sector

Profit

Gross profit

$7.23M
TKNO annual gross profit is $7.23 million

Gross margin

19.16%
TKNO annual gross profit margin is 19.16%

Operating profit

-$26.15M
TKNO annual operating income is -$26.15 million

Operating margin

-69.27%
TKNO annual operating profit margin is -69.27%

Net income

-$26.75M
TKNO annual net profit is -$26.75 million

Net margin

-70.86%
TKNO annual net profit margin is -70.86%

Expenses

Total expenses

$63.89M
TKNO annual total expenses is $63.89 million

Operating expenses

$33.38M
TKNO annual total operating expenses is $33.38 million

Cost of goods sold

$30.51M
TKNO annual cost of goods sold is $30.51 million

Selling, general & administrative expenses

$29.47M
TKNO annual SGA is $29.47 million

Depreciation and amortization

$6.58M
TKNO annual depreciation & amortization is $6.58 million

Interest expense

$687.00K
TKNO annual interest expense is $687.00 thousand

Income tax

-$88.00K
TKNO annual income tax is -$88.00 thousand

EBIT & EBITDA

EBIT

-$26.15M
TKNO annual earnings before interest & taxes is -$26.15 million

EBITDA

-$19.57M
TKNO annual EBITDA is -$19.57 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$118.77M
TKNO annual total assets is $118.77 million

Non current assets

$75.99M
TKNO annual long term assets is $75.99 million

Current assets

$42.78M
TKNO annual total current assets is $42.78 million

Cash and cash equivalents

$3.71M
TKNO annual cash & cash equivalents is $3.71 million

Accounts receivable

$4.31M
TKNO annual accounts receivable is $4.31 million

Inventory

$6.80M
TKNO annual inventory is $6.80 million

Liabilities

Total liabilities

$36.38M
TKNO annual total liabilities is $36.38 million

Long term liabilities

$25.16M
TKNO annual total long term liabilities is $25.16 million

Current liabilities

$11.21M
TKNO annual total current liabilities is $11.21 million

Accounts payable

$825.00K
TKNO annual accounts payable is $825.00 thousand

Debt

Total debt

$30.17M
TKNO annual total debt is $30.17 million

Total debt 1-year change

-0.94%
TKNO annual total debt is down -0.94% year-on-year

Long term debt

$24.33M
TKNO annual long term debt is $24.33 million

Short term debt

$5.84M
TKNO annual short term debt is $5.84 million

Equity & Capital

Shareholders equity

$82.39M
TKNO annual stockholders equity is $82.39 million

Book value

$82.39M
TKNO annual book value is $82.39 million

Retained earnings

-$118.53M
TKNO annual retained earnings is -$118.53 million

Working capital

$31.57M
TKNO annual working capital is $31.57 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$12.39M
TKNO annual cash flow from operations is -$12.39 million

Cash from operations 1-year change

+34.14%
TKNO annual cash flow from operations is up +34.14% year-on-year

Cash from investing

-$27.27M
TKNO annual cash flow from investing activities is -$27.27 million

Cash from investing 1-year change

-252.53%
TKNO annual cash flow from investing activities is down -252.53% year-on-year

Cash from financing

$14.89M
TKNO annual cash flow from financing activities is $14.89 million

Cash from financing 1-year change

+16.34%
TKNO annual cash flow from financing activities is up +16.34% year-on-year

CAPEX

CAPEX

$1.13M
TKNO annual capital expenditures is $1.13 million

CAPEX 1-year change

-85.82%
TKNO annual capital expenditures is down -85.82% year-on-year

Free Cash Flow

Free cash flow

-$13.52M
TKNO annual free cash flow is -$13.52 million

Free cash flow 1-year change

+49.47%
TKNO annual free cash flow is up +49.47% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

19.16%
TKNO annual gross profit margin is 19.16%

Operating margin

-69.27%
TKNO annual operating profit margin is -69.27%

Net margin

-70.86%
TKNO annual net profit margin is -70.86%

ROA & ROE

ROA

-21.62%
TKNO annual return on assets is -21.62%

ROE

-31.02%
TKNO annual return on equity is -31.02%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
TKNO price to earnings ratio value is unknown

PE ratio Sector rank

-
TKNO price to earnings ratio is unknown

PB Ratio

PB ratio

3.74
TKNO price to book ratio is 3.74

PB ratio Sector rank

77.61%
TKNO price to book ratio is higher than 77.61% of companies in Healthcare sector

PS Ratio

PS ratio

8.17
TKNO price to sales ratio is 8.17

PS ratio Sector rank

75.64%
TKNO price to sales ratio is higher than 75.64% of companies in Healthcare sector

Enterprise value

Enterprise value

$334.79M
TKNO enterprise value is $334.79 million

Enterprise value Sector rank

64.6%
TKNO enterprise value is higher than 64.6% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-17.11
TKNO EV/EBITDA is -17.11

EV/EBITDA Sector rank

7.05%
TKNO EV/EBITDA is higher than 7.05% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

3.82
TKNO annual current ratio is 3.82

Quick ratio

3.21
TKNO annual quick ratio is 3.21

Leverage

Debt to equity

0.16
TKNO annual debt to equity ratio is 0.16

Interest coverage ratio

-38.06
TKNO annual interest coverage ratio is -38.06

Risk & Stability

Piotroski F-Score

4
TKNO piotroski f-score is 4

Altman Z-Score

3.60
TKNO altman z-score is 3.60

Analyst ratings

Recent major analysts updates

Jul 10, 24 Stephens & Co.
Overweight
May 14, 24 Stephens & Co.
Overweight
Mar 12, 24 BTIG
Neutral
Jul 12, 23 Keybanc
Sector Weight
Aug 11, 22 Stephens & Co.
Overweight
Mar 16, 22 Stephens & Co.
Overweight
Jul 20, 21 Stephens & Co.
Overweight
Jul 20, 21 Cowen & Co.
Outperform
Jul 20, 21 BTIG
Buy

Institutional Ownership

Similar stocks

RNAC logo
Cartesian Therapeutics (RNAC)
VREX logo
Varex Imaging (VREX)
TCMD logo
Tactile Systems Technology (TCMD)
ALLO logo
Allogene Therapeutics (ALLO)
MREO logo
Mereo BioPharma (MREO)
RIGL logo
Rigel Pharmaceuticals (RIGL)
SPOK logo
Spok Holdings (SPOK)
Oruka Therapeutics (ORKA)
BNTC logo
Benitec Biopharma (BNTC)
  • What is the ticker symbol for Alpha Teknova?
  • Does Alpha Teknova pay dividends?
  • What sector is Alpha Teknova in?
  • What industry is Alpha Teknova in?
  • What country is Alpha Teknova based in?
  • When did Alpha Teknova go public?
  • Is Alpha Teknova in the S&P 500?
  • Is Alpha Teknova in the NASDAQ 100?
  • Is Alpha Teknova in the Dow Jones?
  • When was Alpha Teknova's last earnings report?
  • When does Alpha Teknova report earnings?
  • Should I buy Alpha Teknova stock now?

What is the ticker symbol for Alpha Teknova?

The ticker symbol for Alpha Teknova is NASDAQ:TKNO

Does Alpha Teknova pay dividends?

No, Alpha Teknova does not pay dividends

What sector is Alpha Teknova in?

Alpha Teknova is in the Healthcare sector

What industry is Alpha Teknova in?

Alpha Teknova is in the Drug Manufacturers - Specialty & Generic industry

What country is Alpha Teknova based in?

Alpha Teknova is headquartered in United States

When did Alpha Teknova go public?

Alpha Teknova's initial public offering (IPO) was on June 25, 2021

Is Alpha Teknova in the S&P 500?

No, Alpha Teknova is not included in the S&P 500 index

Is Alpha Teknova in the NASDAQ 100?

No, Alpha Teknova is not included in the NASDAQ 100 index

Is Alpha Teknova in the Dow Jones?

No, Alpha Teknova is not included in the Dow Jones index

When was Alpha Teknova's last earnings report?

Alpha Teknova's most recent earnings report was on Mar 4, 2025

When does Alpha Teknova report earnings?

The next expected earnings date for Alpha Teknova is May 13, 2025

Should I buy Alpha Teknova stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page